See more : Response Genetics, Inc (RGDXQ) Income Statement Analysis – Financial Results
Complete financial analysis of Sekisui Chemical Co., Ltd. (4204.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sekisui Chemical Co., Ltd., a leading company in the Conglomerates industry within the Industrials sector.
- Bionik Laboratories Corp. (BNKL) Income Statement Analysis – Financial Results
- HK Electric Investments and HK Electric Investments Limited (HKVTY) Income Statement Analysis – Financial Results
- Sack Lunch Productions, Inc. (SAKL) Income Statement Analysis – Financial Results
- Everest Global Plc (EVST.L) Income Statement Analysis – Financial Results
- AirSculpt Technologies, Inc. (AIRS) Income Statement Analysis – Financial Results
Sekisui Chemical Co., Ltd. (4204.T)
About Sekisui Chemical Co., Ltd.
Sekisui Chemical Co., Ltd. engages in housing, urban infrastructure and environmental products (UIEP), high-performance plastics (HPP), and medical businesses. The Housing segment engages in the manufacturing, construction, sale, refurbishing, and other operations related to unit housing, real estate, and residential service business. The UIEP segment manufactures, constructs, and sells PVC pipes and joints, polyethylene pipes and joints, pipe and drain renewal materials and construction methods, reinforced plastic pipe, construction materials, and fiber-reinforced foamed urethane. The HPP segment engages in the manufacture and sale of interlayer films for laminated glass, polyolefin foam, tape, LCD fine particles and photosensitive materials, functional resin for infrastructure, diagnostic drugs, and other products. The Medical segment manufactures and sells diagnostic reagents, analyzers, pharmaceutical ingredients, and intermediates. It operates in Japan, the United States, Europe, Asia, and internationally. The company was formerly known as Sekisui Sangyo Co., Ltd. and changed its name to Sekisui Chemical Co., Ltd. in 1948. Sekisui Chemical Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,256.54B | 1,242.52B | 1,157.95B | 1,056.56B | 1,129.25B | 1,142.71B | 1,107.43B | 1,065.78B | 1,096.32B | 1,112.75B | 1,110.85B | 1,032.43B | 965.09B | 915.49B | 858.51B | 934.23B | 958.67B | 926.16B | 885.07B | 856.94B |
| Cost of Revenue | 864.34B | 865.28B | 801.99B | 726.17B | 766.55B | 774.65B | 745.35B | 712.26B | 750.51B | 775.13B | 774.75B | 729.97B | 679.53B | 645.47B | 606.12B | 680.45B | 685.90B | 656.50B | 627.28B | 605.67B |
| Gross Profit | 392.20B | 377.24B | 355.95B | 330.39B | 362.70B | 368.07B | 362.08B | 353.52B | 345.80B | 337.62B | 336.10B | 302.46B | 285.56B | 270.02B | 252.39B | 253.78B | 272.77B | 269.66B | 257.79B | 251.26B |
| Gross Profit Ratio | 31.21% | 30.36% | 30.74% | 31.27% | 32.12% | 32.21% | 32.70% | 33.17% | 31.54% | 30.34% | 30.26% | 29.30% | 29.59% | 29.49% | 29.40% | 27.16% | 28.45% | 29.12% | 29.13% | 29.32% |
| Research & Development | 41.70B | 40.47B | 37.01B | 35.11B | 37.15B | 38.84B | 36.97B | 34.17B | 31.69B | 29.45B | 27.72B | 25.89B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 267.20B | 197.53B | 185.66B | 187.43B | 196.29B | 193.20B | 188.61B | 186.67B | 187.43B | 186.39B | 188.84B | 182.60B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 30.59B | 32.64B | 30.28B | 25.87B | 27.38B | 27.86B | 26.32B | 26.01B | 27.20B | 27.04B | 27.83B | 25.28B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 297.80B | 230.17B | 215.94B | 213.30B | 223.67B | 221.06B | 214.92B | 212.68B | 214.63B | 213.43B | 216.68B | 207.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | -41.70B | 1.82B | -387.00M | -11.94B | -8.47B | -11.05B | -9.71B | -10.61B | -11.19B | -8.80B | -6.43B | -5.46B | 119.00M | 1.37B | -3.89B | -1.66B | -423.00M | 1.19B | 2.90B | -1.61B |
| Operating Expenses | 297.80B | 285.57B | 267.07B | 263.08B | 274.93B | 272.38B | 262.85B | 257.04B | 255.98B | 251.85B | 253.56B | 242.84B | 230.95B | 220.69B | 216.43B | 220.19B | 229.77B | 224.50B | 217.50B | 214.82B |
| Cost & Expenses | 1,162.14B | 1,150.86B | 1,069.07B | 989.26B | 1,041.48B | 1,047.03B | 1,008.20B | 969.30B | 1,006.49B | 1,026.98B | 1,028.31B | 972.81B | 910.48B | 866.16B | 822.56B | 900.64B | 915.67B | 881.01B | 844.78B | 820.49B |
| Interest Income | 1.85B | 1.21B | 544.00M | 484.00M | 957.00M | 1.07B | 963.00M | 748.00M | 859.00M | 936.00M | 1.03B | 909.00M | 695.00M | 646.00M | 790.00M | 1.23B | 1.30B | 910.00M | 1.03B | 884.00M |
| Interest Expense | 1.10B | 871.00M | 774.00M | 861.00M | 695.00M | 480.00M | 533.00M | 610.00M | 1.15B | 1.43B | 2.27B | 2.55B | 2.43B | 2.30B | 2.28B | 2.51B | 2.14B | 1.76B | 2.13B | 2.48B |
| Depreciation & Amortization | 52.67B | 50.43B | 48.70B | 49.35B | 45.26B | 41.64B | 38.43B | 36.96B | 36.89B | 33.55B | 37.33B | 38.13B | 38.52B | 37.26B | 37.61B | 38.96B | 32.20B | 26.05B | 25.54B | 26.34B |
| EBITDA | 165.25B | 150.80B | 137.58B | 116.65B | 129.74B | 137.33B | 137.67B | 133.44B | 126.71B | 119.32B | 119.88B | 85.17B | 90.20B | 79.36B | 63.23B | 54.31B | 72.89B | 66.66B | 59.50B | 60.94B |
| EBITDA Ratio | 13.15% | 12.58% | 12.65% | 10.68% | 11.79% | 11.84% | 12.00% | 12.11% | 10.88% | 11.25% | 11.06% | 9.82% | 9.86% | 9.60% | 8.27% | 7.54% | 7.60% | 8.07% | 8.07% | 7.80% |
| Operating Income | 94.40B | 91.67B | 88.88B | 67.30B | 87.77B | 95.69B | 99.23B | 96.48B | 89.82B | 85.76B | 82.54B | 59.62B | 56.59B | 50.59B | 33.36B | 31.49B | 40.69B | 48.67B | 45.93B | 40.47B |
| Operating Income Ratio | 7.51% | 7.38% | 7.68% | 6.37% | 7.77% | 8.37% | 8.96% | 9.05% | 8.19% | 7.71% | 7.43% | 5.77% | 5.86% | 5.53% | 3.89% | 3.37% | 4.24% | 5.25% | 5.19% | 4.72% |
| Total Other Income/Expenses | 17.08B | 7.83B | -19.02B | -4.12B | -4.19B | -1.78B | -4.89B | -13.63B | -11.87B | -1.53B | -10.12B | -15.13B | -5.37B | -9.54B | -12.61B | -20.75B | 1.99B | -6.30B | -8.45B | -4.34B |
| Income Before Tax | 111.48B | 99.49B | 69.86B | 63.18B | 83.58B | 93.91B | 94.34B | 82.85B | 77.95B | 84.23B | 72.43B | 44.50B | 49.24B | 39.80B | 23.34B | 12.84B | 44.99B | 38.86B | 31.84B | 32.11B |
| Income Before Tax Ratio | 8.87% | 8.01% | 6.03% | 5.98% | 7.40% | 8.22% | 8.52% | 7.77% | 7.11% | 7.57% | 6.52% | 4.31% | 5.10% | 4.35% | 2.72% | 1.37% | 4.69% | 4.20% | 3.60% | 3.75% |
| Income Tax Expense | 32.42B | 28.73B | 31.10B | 19.90B | 22.62B | 25.43B | 27.63B | 20.95B | 20.22B | 29.94B | 30.06B | 13.27B | 20.19B | 15.12B | 10.51B | 11.52B | 19.95B | 12.69B | 11.17B | 10.23B |
| Net Income | 77.93B | 69.26B | 37.07B | 41.54B | 59.18B | 66.09B | 63.46B | 60.85B | 56.65B | 53.00B | 41.19B | 30.17B | 28.12B | 23.57B | 11.63B | 1.01B | 24.30B | 25.54B | 20.23B | 22.29B |
| Net Income Ratio | 6.20% | 5.57% | 3.20% | 3.93% | 5.24% | 5.78% | 5.73% | 5.71% | 5.17% | 4.76% | 3.71% | 2.92% | 2.91% | 2.58% | 1.35% | 0.11% | 2.53% | 2.76% | 2.29% | 2.60% |
| EPS | 183.48 | 159.19 | 83.17 | 91.92 | 128.80 | 141.74 | 133.80 | 126.13 | 115.08 | 104.73 | 80.13 | 58.53 | 53.96 | 44.92 | 22.13 | 1.93 | 46.16 | 48.19 | 37.78 | 41.48 |
| EPS Diluted | 183.48 | 159.19 | 83.17 | 91.92 | 128.80 | 141.64 | 133.58 | 125.95 | 114.88 | 104.55 | 79.94 | 58.50 | 53.94 | 44.92 | 22.13 | 1.93 | 46.15 | 48.13 | 37.75 | 41.42 |
| Weighted Avg Shares Out | 424.73M | 435.10M | 445.70M | 451.96M | 459.49M | 466.30M | 474.28M | 482.44M | 492.30M | 506.03M | 514.06M | 515.53M | 521.03M | 524.81M | 525.36M | 525.41M | 526.39M | 529.99M | 528.50M | 537.27M |
| Weighted Avg Shares Out (Dil) | 424.73M | 435.10M | 445.70M | 451.96M | 459.59M | 466.63M | 475.06M | 483.13M | 493.15M | 506.89M | 515.26M | 515.79M | 521.25M | 524.81M | 525.36M | 525.41M | 526.54M | 530.60M | 535.87M | 538.05M |
Source: https://incomestatements.info
Category: Stock Reports